GBA1 and Gaucher disease: We then reasoned that ambroxol hydrochloride, a small molecule previously shown to improve glucosylceramidase function in Gaucher disease (Maegawa et al., 2009), might ameliorate the cellular phenotypes in Gaucher disease and GBA mutation heterozygotes.